Duration of Androgen Suppression in the Treatment of Prostate Cancer

Authors:
  • TRTheodorus M. de Reijke
    Theodorus M. de Reijke
  • GTGeertjan Van Tienhoven
    Geertjan Van Tienhoven
  • ABAlphonsus C.M. Van Den Bergh
    Alphonsus C.M. Van Den Bergh
  • PPPhilip M.P. Poortmans
    Philip M.P. Poortmans
  • EGEliahu Gez
    Eliahu Gez
  • PKPaul Kil
    Paul Kil
  • AAAtif Akdas
    Atif Akdas
  • GSGuy Soete
    Guy Soete
  • OKOleg Kariakine
    Oleg Kariakine
  • ESElsbietha M. van der Steen-Banasik
    Elsbietha M. van der Steen-Banasik

Abstract
The combination of radiotherapy plus long-term medical suppression of androgens (≥2 years) improves overall survival in patients with locally advanced prostate cancer. We compared the use of radiotherapy plus short-term androgen suppression with the use of radiotherapy plus long-term androgen suppression in the treatment of locally advanced prostate cancer.

This publication has 26 references indexed in Scilit: